Shares of Liquidia Co. (NASDAQ:LQDA – Get Rating) have been given an average recommendation of “Moderate Buy” by the six research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $13.67.
LQDA has been the topic of several recent analyst reports. Needham & Company LLC increased their price objective on Liquidia from $12.00 to $16.00 and gave the company a “buy” rating in a research report on Thursday, September 1st. Wedbush reissued an “underperform” rating and set a $3.00 target price on shares of Liquidia in a research note on Wednesday, November 9th. Finally, BTIG Research lifted their price objective on Liquidia to $20.00 in a research note on Tuesday, September 6th.
Insider Activity at Liquidia
In other news, CFO Michael Kaseta bought 8,000 shares of the business’s stock in a transaction dated Tuesday, September 13th. The shares were acquired at an average price of $5.99 per share, for a total transaction of $47,920.00. Following the completion of the transaction, the chief financial officer now owns 37,877 shares of the company’s stock, valued at $226,883.23. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Over the last three months, insiders purchased 12,078 shares of company stock worth $67,902. Company insiders own 29.20% of the company’s stock.
Institutional Trading of Liquidia
Institutional investors and hedge funds have recently made changes to their positions in the company. Allspring Global Investments Holdings LLC bought a new position in shares of Liquidia during the third quarter worth about $28,000. UBS Group AG lifted its position in Liquidia by 134.0% in the 2nd quarter. UBS Group AG now owns 7,948 shares of the company’s stock worth $35,000 after buying an additional 4,552 shares in the last quarter. Legal & General Group Plc bought a new position in shares of Liquidia during the 2nd quarter valued at $38,000. BNP Paribas Arbitrage SA grew its position in Liquidia by 42.8% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 10,682 shares of the company’s stock worth $47,000 after purchasing an additional 3,200 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in Liquidia in the 2nd quarter worth $60,000. 35.79% of the stock is currently owned by institutional investors and hedge funds.
Liquidia Trading Up 1.9 %
LQDA opened at $4.89 on Thursday. The stock has a fifty day simple moving average of $5.19 and a two-hundred day simple moving average of $5.19. The company has a market cap of $315.38 million, a price-to-earnings ratio of -5.96 and a beta of 0.24. Liquidia has a 12-month low of $3.26 and a 12-month high of $8.79.
Liquidia Company Profile
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Liquidia, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Liquidia wasn’t on the list.
While Liquidia currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Read More: Liquidia Co. (NASDAQ:LQDA) Receives Average Rating of “Moderate Buy” from Brokerages